This medicinal product is for diagnostic use only
PYLCLARI® is indicated for the detection of prostate-specific membrane antigen (PSMA) positive lesions with positron emission tomography (PET) in adults with prostate cancer (PCa) in the following clinical settings:
Detailed recommendations for the use of this product can be found in the Summary of Product Characteristics (SmPC)
Looking for training on how to interpret piflufolastat (18F) images?
Refresh your knowledge on guidelines and test yourself with some clinical cases interpretations
Looking for training on how to interpret piflufolastat (18F) images?
Refresh your knowledge on guidelines and test yourself with some clinical cases interpretations
Error: Formulario de contacto no encontrado.
Copyright © 2017-2024. Website content is subject to copyright protection.
Please refer to Terms of use. for more information.